BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 11039551)

  • 1. Effects of 0.005% latanoprost solution on intraocular pressure in healthy dogs and cats.
    Studer ME; Martin CL; Stiles J
    Am J Vet Res; 2000 Oct; 61(10):1220-4. PubMed ID: 11039551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of an unfixed combination of latanoprost and pilocarpine on the intraocular pressure and pupil size of normal dogs.
    Sarchahi AA; Abbasi N; Gholipour MA
    Vet Ophthalmol; 2012 Mar; 15 Suppl 1():64-70. PubMed ID: 22050700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of two- and three-times-daily topical ophthalmic application of 0.005% latanoprost solution in clinically normal dogs.
    Tofflemire KL; Whitley EM; Allbaugh RA; Ben-Shlomo G; Robinson CC; Overton TL; Thiessen CE; Evans EA; Griggs AN; Adelman SA; Ludwig AL; Jens JK; Ellinwood NM; Peterson CS; Whitley RD
    Am J Vet Res; 2015 Jul; 76(7):625-31. PubMed ID: 26111092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of topical administration of 0.005% latanoprost solution on eyes of clinically normal horses.
    Willis AM; Diehl KA; Hoshaw-Woodard S; Kobayashi I; Vitucci MP; Schmall LM
    Am J Vet Res; 2001 Dec; 62(12):1945-51. PubMed ID: 11763186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of different dose schedules of latanoprost on intraocular pressure and pupil size in the glaucomatous Beagle.
    Gelatt KN; MacKay EO
    Vet Ophthalmol; 2001 Dec; 4(4):283-8. PubMed ID: 11906665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of topical ophthalmic latanoprost 0.005% solution alone and in combination with diclofenac 0.1% solution in healthy horses: a pilot study.
    Tofflemire K; Whitley EM; Allbaugh R; Ben-Shlomo G; Griggs A; Strong T; Whitley RD
    Vet Ophthalmol; 2017 Sep; 20(5):398-404. PubMed ID: 27791324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of topical administration of latanoprost, timolol, or a combination of latanoprost and timolol on intraocular pressure, pupil size, and heart rate in clinically normal dogs.
    Smith LN; Miller PE; Felchle LM
    Am J Vet Res; 2010 Sep; 71(9):1055-61. PubMed ID: 20807145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of topical latanoprost 0.005% on intraocular pressure and pupil diameter in normal and glaucomatous cats.
    McDonald JE; Kiland JA; Kaufman PL; Bentley E; Ellinwood NM; McLellan GJ
    Vet Ophthalmol; 2016 Jul; 19 Suppl 1(Suppl 1):13-23. PubMed ID: 26183373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of travoprost 0.004% compared with latanoprost 0.005% on the intraocular pressure of normal dogs.
    Carvalho AB; Laus JL; Costa VP; Barros PS; Silveira PR
    Vet Ophthalmol; 2006; 9(2):121-5. PubMed ID: 16497237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of intraocular pressure with treatment of latanoprost once daily in patients with normal-pressure glaucoma.
    Rulo AH; Greve EL; Geijssen HC; Hoyng PF
    Ophthalmology; 1996 Aug; 103(8):1276-82. PubMed ID: 8764799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Additive ocular hypotensive effect of latanoprost and acetazolamide. A short-term study in patients with elevated intraocular pressure.
    Rulo AH; Greve EL; Hoyng PF
    Ophthalmology; 1997 Sep; 104(9):1503-7. PubMed ID: 9307648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of bimatoprost and unoprostone isopropyl on the intraocular pressure of normal cats.
    Bartoe JT; Davidson HJ; Horton MT; Jung Y; Brightman AH
    Vet Ophthalmol; 2005; 8(4):247-52. PubMed ID: 16008704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of topical ophthalmic latanoprost on intraocular pressure in normal horses.
    Davidson HJ; Pinard CL; Keil SM; Brightman AH; Sargeant JM
    Vet Ther; 2002; 3(1):72-80. PubMed ID: 12050830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ocular effects of topical 0.03% bimatoprost solution in normotensive feline eyes.
    Regnier A; Lemagne C; Ponchet A; Cazalot G; Concordet D; Gelatt KN
    Vet Ophthalmol; 2006; 9(1):39-43. PubMed ID: 16409244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative study of two dose regimens of latanoprost in patients with elevated intraocular pressure.
    Lusky M; Ticho U; Glovinsky J; Weinberger D; Nesher R; Yassur Y; Melamed S
    Ophthalmology; 1997 Oct; 104(10):1720-4. PubMed ID: 9331215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of prostaglandin-mediated and cholinergic-mediated miosis on morphology of the ciliary cleft region in dogs.
    Park S; Kang S; Lim J; Park E; Nam T; Jeong S; Seo K
    Am J Vet Res; 2018 Sep; 79(9):980-985. PubMed ID: 30153051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of latanoprost 0.005% once daily versus 0.0015% twice daily on intraocular pressure and aqueous humour protein concentration in glaucoma patients. A randomized, double-masked comparison with timolol 0.5%.
    Diestelhorst M; Roters S; Krieglstein GK
    Graefes Arch Clin Exp Ophthalmol; 1997 Jan; 235(1):20-6. PubMed ID: 9034838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraocular pressure lowering effect of brinzolamide 1.0% as adjunctive therapy to latanoprost 0.005% in patients with open angle glaucoma or ocular hypertension: an uncontrolled, open-label study.
    Shoji N; Ogata H; Suyama H; Ishikawa H; Suzuki H; Morita T; Kawai H; Nishimoto H; Nemoto T; Shimizu K
    Curr Med Res Opin; 2005 Apr; 21(4):503-8. PubMed ID: 15899098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the intraocular pressure-lowering effect of latanoprost and timolol in patients with chronic angle closure glaucoma: a preliminary study.
    Aung T; Wong HT; Yip CC; Leong JY; Chan YH; Chew PT
    Ophthalmology; 2000 Jun; 107(6):1178-83. PubMed ID: 10857840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of non-steroidal anti-inflammatory ophthalmic solution on intraocular pressure reduction by latanoprost.
    Kashiwagi K; Tsukahara S
    Br J Ophthalmol; 2003 Mar; 87(3):297-301. PubMed ID: 12598441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.